Stocksigma LogoStocksigma Logo

Cohance Lifesciences Revises Q2 and H1 FY27 Earnings Conference Call Timing

Cohance Lifesciences Limited has rescheduled its investor and analyst conference call to discuss Q2 and H1 FY27 unaudited financial results

Cohance Lifesciences Revises Q2 and H1 FY27 Earnings Conference Call Timing

Cohance Lifesciences Ltd 路 Intimation 路 04 Nov 2026, 1:07 am

Cohance Lifesciences Revises Q2 and H1 FY27 Earnings Conference Call Timing Cohance Lifesciences Limited has rescheduled its investor and analyst conference call to discuss Q2 and H1 FY27 unaudited financial results. The call is now set for 6th Nov'26 at 6:00 p.m. IST, advanced from the previously scheduled time of 6:30 p.m. IST. The company will announce its financial results earlier on the same day, followed by management discussion and an interactive Q&A session. Primary domestic dial-ins include +91 22 6280 1141 and +91 22 7115 8042, alongside international toll-free options.

Original exchange filing (PDF)

More announcements from Cohance Lifesciences Ltd

All Cohance Lifesciences Ltd announcements